Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Relationship Between Obesity and Bone Mineral Density: Evidence for a Role of Peroxisome Proliferator-Activated Receptor Gamma Pubmed



Mirzaei K1
Authors

Source: Minerva endocrinologica Published:2015


Abstract

AIM: Peroxisome proliferator-activated receptor γ (PPAR γ) is a critical factor for some pathways that involve in adipogenesis and osteogenesis. The aim of study was to compare PPARγ gene expression, different cytokines' levels and bone markers in osteopenic and non-osteopenic obese subjects.; METHODS: A total of 265 obese participants recruited in the current case-control cross sectional study. BMD at region of lumbar spine and hip were measured in all participants. We categorized all participants into two osteopenic and non-osteopenic groups.; RESULTS: Of the 265 obese participants, 77 (29.05 %) were osteopenic and 188 (70.95%) were non-osteopenic. We found significantly higher concentration of crosslaps and IL6 and lower free fat mass in osteopenic group. The relative gene expression of PPAR γ in osteopenic group was significantly higher than non-osteopenic group. Based on relative gene expression tertiles participants were rearranged all participants into two new groups; low expressed PPAR γ with low PPAR γ gene expression≤75% and high expressed PPAR γ with PPAR γ gene expression>75%. The levels of fat percents, triglyceride, LDL, HDL and total cholesterol in high expressed PPAR γ group were significantly higher than low expressed PPAR γ group. Also, significantly higher concentration of IL10, IL6 and TNFα and lower concentration of hs-CRP were detected in high expressed group compare to low expressed PPAR γ group. The BMD, T-score and Z-score in high expressed PPAR γ group were lower than low expressed PPAR γ group.; CONCLUSION: Our findings suggest that the over expression of PPARγ in obese individual's PBMCs may have a critical role in relationship between obesity and bone loss. Further studies recommended clarifying the mechanism of PPARγ in bone turnover in obese subjects.
Related Docs
View other Related Docs
1. Dietary Fat Intake Associated With Bone Mineral Density Among Visfatin Genotype in Obese People, British Journal of Nutrition (2018)
2. Obesity and Pro12ala Polymorphism of Peroxisome Proliferator-Activated Receptor-Gamma Gene in Healthy Adults: A Systematic Review and Meta-Analysis, Annals of Nutrition and Metabolism (2015)
3. Peroxisome Proliferator-Activated Receptor Gamma Expression in Peripheral Blood Mononuclear Cells and Angiopoietin-Like Protein 4 Levels in Obese Children and Adolescents, Journal of Endocrinological Investigation (2018)
Experts (# of related papers)
View all Related Experts
Khadijeh Mirzaei (3)
Solaleh Emamgholipour (3)
Other Related Docs
4. Principal Component Analysis of Adipose Tissue Gene Expression of Lipogenic and Adipogenic Factors in Obesity, BMC Endocrine Disorders (2023)
5. New Trends in the Pharmacological Intervention of Ppars in Obesity: Role of Natural and Synthetic Compounds, Current Medicinal Chemistry (2021)
6. Evaluation of the Expression Pattern and Diagnostic Value of Pparγ in Malignant and Benign Primary Bone Tumors, BMC Musculoskeletal Disorders (2022)
7. The Associations Between Dietary Patterns and Bone Health, According to the Tgf-Β1 T869→C Polymorphism, in Postmenopausal Iranian Women, Aging Clinical and Experimental Research (2018)
8. Comparison of Maternal Isocaloric High Carbohydrate and High Fat Diets on Osteogenic and Adipogenic Genes Expression in Adolescent Mice Offspring, Nutrition and Metabolism (2016)
9. Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes, Current Diabetes Reviews (2020)
10. Effects of Dha Supplementation on Vascular Function, Telomerase Activity in Pbmc, Expression of Inflammatory Cytokines, and Pparγ-Lxrα-Abca1 Pathway in Patients With Type 2 Diabetes Mellitus: Study Protocol for Randomized Controlled Clinical Trial, Acta Medica Iranica (2016)
11. The Link Between Osteoporosis and Cardiovascular Diseases: A Review of Shared Mechanisms, Risk Factors, and Therapeutic Approaches, Osteoporosis International (2025)
12. Association of Vitamin D Receptor Gene Polymorphism With the Occurrence of Low Bone Density, Osteopenia, and Osteoporosis in Patients With Type 2 Diabetes, Journal of Diabetes and Metabolic Disorders (2021)
13. Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1Α Variation: A Closer Look at Obesity Onset Age and Its Related Metabolic Status and Body Composition, Applied Physiology# Nutrition and Metabolism (2018)
14. Alterations of Socs1 and Socs3 Transcript Levels, But Not Promoter Methylation Levels in Subcutaneous Adipose Tissues in Obese Women, BMC Endocrine Disorders (2023)
15. Oleoylethanolamide Supplementation in Obese Patients Newly Diagnosed With Non-Alcoholic Fatty Liver Disease: Effects on Metabolic Parameters, Anthropometric Indices, and Expression of Ppar-Α, Ucp1, and Ucp2 Genes, Pharmacological Research (2020)
16. Pparg (Pro12ala) Genetic Variant and Risk of T2dm: A Systematic Review and Meta-Analysis, Scientific Reports (2020)
17. Increased Mrna Expression of Ctrp3 and Ctrp9 in Adipose Tissue From Obese Women: Is It Linked to Obesity-Related Parameters and Mrna Expression of Inflammatory Cytokines?, Reports of Biochemistry and Molecular Biology (2020)
18. The Gene Expression of Long Non-Coding Rnas (Lncrnas): Meg3 and H19 in Adipose Tissues From Obese Women and Its Association With Insulin Resistance and Obesity Indices, Journal of Clinical Laboratory Analysis (2021)
19. The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density, Risk Management and Healthcare Policy (2019)
20. Association Between Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Gene With Overweight and Obesity Risk: Case–Control Study and Meta-Analysis, Human Gene (2022)